看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 31.3x - 34.5x | 32.9x |
| Selected Fwd P/E Multiple | 22.3x - 24.7x | 23.5x |
| Fair Value | €16.16 - €17.86 | €17.01 |
| Upside | -33.6% - -26.6% | -30.1% |
| Benchmarks | - | Full Ticker |
| Elekta AB (publ) | - | OM:EKTAB |
| Sectra AB (publ) | - | OM:SECTB |
| Koninklijke Philips N.V. | - | DB:PHI1 |
| Medhelp Care Aktiebolag (publ) | - | OM:MEDHLP |
| Aino Health AB (publ) | - | OM:AINO |
| RaySearch Laboratories AB (publ) | - | DB:27R |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| EKTA B | SECT B | PHI1 | MEDHLP | AINO | 27R | |||
| OM:EKTAB | OM:SECTB | DB:PHI1 | OM:MEDHLP | OM:AINO | DB:27R | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | -26.2% | 18.9% | NM- | -14.6% | NM- | 32.2% | ||
| 3Y CAGR | -41.0% | 21.4% | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -81.8% | 31.5% | 130.6% | 159.4% | 30.4% | 27.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 7.0% | 15.5% | 2.2% | -6.6% | -54.8% | 3.7% | ||
| Prior Fiscal Year | 7.2% | 14.1% | -2.5% | -12.2% | -44.6% | 8.0% | ||
| Latest Fiscal Year | 1.3% | 17.0% | -4.7% | 2.3% | -41.4% | 17.1% | ||
| Latest Twelve Months | 1.3% | 17.0% | 1.0% | 6.8% | -29.7% | 15.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 9.8x | 116.0x | 17.3x | 27.3x | -10.5x | 34.8x | ||
| Price / LTM Sales | 1.0x | 19.9x | 1.2x | 2.2x | 2.0x | 7.5x | ||
| LTM P/E Ratio | 78.1x | 117.2x | 130.3x | 32.7x | -6.7x | 48.6x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -6.7x | 78.1x | 130.3x | |||||
| Historical LTM P/E Ratio | -368.4x | 42.3x | 118.0x | |||||
| Selected P/E Multiple | 31.3x | 32.9x | 34.5x | |||||
| (x) LTM Net Income | 193 | 193 | 193 | |||||
| (=) Equity Value | 6,030 | 6,348 | 6,665 | |||||
| (/) Shares Outstanding | 34.3 | 34.3 | 34.3 | |||||
| Implied Value Range | 175.90 | 185.16 | 194.42 | |||||
| FX Rate: SEK/EUR | 11.2 | 11.2 | 11.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 15.73 | 16.56 | 17.39 | 24.35 | ||||
| Upside / (Downside) | -35.4% | -32.0% | -28.6% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | EKTA B | SECT B | PHI1 | MEDHLP | AINO | 27R | |
| Value of Common Equity | 18,325 | 67,055 | 22,215 | 207 | 43 | 9,334 | |
| (/) Shares Outstanding | 382.1 | 192.7 | 950.6 | 30.4 | 204.6 | 34.3 | |
| Implied Stock Price | 47.96 | 348.00 | 23.37 | 6.80 | 0.21 | 272.26 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 11.18 | |
| Implied Stock Price (Trading Cur) | 47.96 | 348.00 | 23.37 | 6.80 | 0.21 | 24.35 | |
| Trading Currency | SEK | SEK | EUR | SEK | SEK | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 11.18 | |